Form 4: CVS Health Executive Heidi Capozzi Trades Shares

Heidi B. Capozzi, EVP and Chief People Officer at CVS Health Corp, reported transactions involving restricted stock and stock options.

Summary

• Heidi B. Capozzi, EVP and Chief People Officer at CVS Health Corp, reported transactions on March 31, 2026, and April 1, 2026.
• On March 31, 2026, 10,025 shares of restricted common stock were acquired at a price of $71.82, bringing the total beneficial ownership of restricted stock to 84,450 shares.
• Also on March 31, 2026, a stock option for 64,670 shares was granted with an exercise price of $71.82, exercisable in three equal annual installments starting March 31, 2027, and expiring March 31, 2036.
• On April 1, 2026, 1,334 shares of common stock were disposed of at a price of $72.49, reducing beneficial ownership to 13,023 shares. This disposal was related to the surrender of shares to cover withholding taxes upon the vesting and settlement of restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine executive stock transactions and compensation plan details rather than significant company performance indicators or strategic shifts.

Positives

• Acquisition of 10,025 restricted stock units, indicating continued equity ownership by a key executive.
• Grant of stock options for 64,670 shares, suggesting a long-term incentive and alignment with company performance.

Negatives

• Disposal of 1,334 shares to cover tax withholding obligations, which reduces immediate shareholding.

Future Outlook

The filing details the terms of stock options and restricted stock units, including their vesting and exercise schedules, which implies a forward-looking compensation structure for the executive.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executive stock transactions. The details provided for CVS Health's executive Heidi B. Capozzi align with typical executive compensation practices involving stock options and restricted stock units, which are common in the pharmaceutical and healthcare retail sectors.

Stakeholder Impact

• Shareholders: The transactions reflect executive compensation and equity incentives, which are standard components of corporate governance and can influence long-term shareholder value.
• Employees: The executive's equity awards are part of the overall compensation structure, which can impact employee morale and retention.
• Management: The filing details the equity holdings and incentives of a key executive, providing transparency on their financial stake in the company.

Next Steps

• Vesting of restricted stock units in three equal installments starting March 31, 2027.
• Exercisability of stock options in three equal annual installments starting March 31, 2027.

Key Dates

Keywords

CVS Health, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Executive Compensation, Beneficial Ownership, Securities Exchange Act